These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30974394)

  • 1. Beyond speed: Gait changes after botulinum toxin injections in chronic stroke survivors (a systematic review).
    Cofré Lizama LE; Khan F; Galea MP
    Gait Posture; 2019 May; 70():389-396. PubMed ID: 30974394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of botulinum toxin injections on gait control in spastic stroke patients presenting with a stiff-knee gait.
    Bleyenheuft C; Cockx S; Caty G; Stoquart G; Lejeune T; Detrembleur C
    Gait Posture; 2009 Aug; 30(2):168-72. PubMed ID: 19442523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of simultaneous botulinum toxin injections into several muscles on impairment, activity, participation, and quality of life among stroke patients presenting with a stiff knee gait.
    Caty GD; Detrembleur C; Bleyenheuft C; Deltombe T; Lejeune TM
    Stroke; 2008 Oct; 39(10):2803-8. PubMed ID: 18635841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Botulinum Toxin Type A Injection in the Rectus Femoris in Stroke Patients Walking With a Stiff Knee Gait: A Randomized Controlled Trial.
    Tenniglo MJB; Nene AV; Rietman JS; Buurke JH; Prinsen EC
    Neurorehabil Neural Repair; 2023 Sep; 37(9):640-651. PubMed ID: 37644725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of botulinum toxin injection on length and force of the rectus femoris and triceps surae muscles during locomotion in patients with chronic hemiparesis (FOLOTOX).
    Supiot A; Geiger M; Bensmail D; Aegerter P; Pradon D; Roche N
    BMC Neurol; 2018 Aug; 18(1):104. PubMed ID: 30068305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are gait and mobility measures responsive to change following botulinum toxin injections in adults with lower limb spasticity?
    Chan J; Winter A; Palit M; Sturt R; Graaff Sd; Holland AE
    Disabil Rehabil; 2013 Jun; 35(12):959-67. PubMed ID: 23025332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
    Read FA; Boyd RN; Barber LA
    Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in electromyographic activity after botulinum toxin injection of the rectus femoris in patients with hemiparesis walking with a stiff-knee gait.
    Boudarham J; Hameau S; Pradon D; Bensmail D; Roche N; Zory R
    J Electromyogr Kinesiol; 2013 Oct; 23(5):1036-43. PubMed ID: 23928281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional outcomes following ultrasound-guided botulinum toxin type A injections to reduce spastic equinovarus in adult post-stroke patients.
    Aktürk S; Büyükavcı R; Ersoy Y
    Toxicon; 2018 May; 146():95-98. PubMed ID: 29530514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidimensional evaluation of changes in limb function following botulinum toxin injection in persons with stroke.
    Amatya B; Cofré Lizama LE; Elmalik A; Bastani A; Galea MP; Khan F
    NeuroRehabilitation; 2019; 45(1):67-78. PubMed ID: 31403954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of botulinum toxin injection on length and lengthening velocity of rectus femoris during gait in hemiparetic patients.
    Lampire N; Roche N; Carne P; Cheze L; Pradon D
    Clin Biomech (Bristol, Avon); 2013 Feb; 28(2):164-70. PubMed ID: 23332578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients.
    Hesse S; Krajnik J; Luecke D; Jahnke MT; Gregoric M; Mauritz KH
    Stroke; 1996 Mar; 27(3):455-60. PubMed ID: 8610313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How effective is physical therapy for gait muscle activity in hemiparetic patients who receive botulinum toxin injections?
    Fujita K; Miaki H; Hori H; Kobayashi Y; Nakagawa T
    Eur J Phys Rehabil Med; 2019 Feb; 55(1):8-18. PubMed ID: 29898587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isokinetic assessment of the effects of botulinum toxin injection on spasticity and voluntary strength in patients with spastic hemiparesis.
    Hameau S; Bensmail D; Robertson J; Boudarham J; Roche N; Zory R
    Eur J Phys Rehabil Med; 2014 Oct; 50(5):515-23. PubMed ID: 24651151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of gait parameters to predict the effectiveness of botulinum toxin injection in the spastic rectus femoris muscle of stroke patients with stiff knee gait.
    Roche N; Boudarham J; Hardy A; Bonnyaud C; Bensmail B
    Eur J Phys Rehabil Med; 2015 Aug; 51(4):361-70. PubMed ID: 25213306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of onabotulinum toxin A injection into rectus femoris muscle in hemiplegic stroke patients with stiff-knee gait: a placebo-controlled, nonrandomized trial.
    Tok F; Balaban B; Yaşar E; Alaca R; Tan AK
    Am J Phys Med Rehabil; 2012 Apr; 91(4):321-6. PubMed ID: 22311056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of botulinum toxin injection in the rectus femoris on stiff-knee gait in people with stroke: a prospective observational study.
    Stoquart GG; Detrembleur C; Palumbo S; Deltombe T; Lejeune TM
    Arch Phys Med Rehabil; 2008 Jan; 89(1):56-61. PubMed ID: 18164331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meaningful improvement in walking performance after Botulinum neurotoxin A (BoNT-A) in chronic spastic patients.
    Cioncoloni D; Taddei S; Bielli S; Annunziata P; Mazzocchio R
    NeuroRehabilitation; 2014; 34(1):185-92. PubMed ID: 24284465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of botulinum neurotoxin on spatio-temporal gait parameters of patients with chronic stroke: a prospective open-label study.
    Gastaldi L; Lisco G; Pastorelli S; Dimanico U
    Eur J Phys Rehabil Med; 2015 Oct; 51(5):609-18. PubMed ID: 25519765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum Toxin Type A Treatment Combined with Intensive Rehabilitation for Gait Poststroke: A Preliminary Study.
    Uchiyama Y; Koyama T; Wada Y; Katsutani M; Kodama N; Domen K
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1975-1986. PubMed ID: 29610039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.